Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis
Condition: Seborrheic Dermatitis Interventions: Drug: Omiganan; Drug: Ketoconazole; Drug: Placebo Sponsor: Cutanea Life Sciences, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials